Deutsch English Français

Contact

EP2424368

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP2424368

EP2424368 - PYRROLOTRIAZINE COMPOUNDS [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 06.11.2015 Database last updated on 12.07.2024
Most recent event Tooltip	22.06.2018	Lapse of the patent in a contracting state New state(s): MK	published on 25.07.2018 [2018/30]
Applicant(s)	For all designated states Locus Pharmaceuticals, Inc. 3711 Market Street, 8th Floor Philadelphia, PA 19104 / US
	[2015/01]
Former [2012/10]	For all designated states Locus Pharmaceuticals, Inc. 4 Tower Bridge, Suite 400 200 Barr Harbor Drive West Conshohocken, PA 19428 / US
Inventor(s)	01 / KONTEATIS, Zenon 137 Southern Blvd. Chatham Twp. New Jersey 07928 / US
	02 / MOFFETT, Kristofer 25 Hastings Dr. Blue Bell Pennsylvania 19422 / US
	03 / LEE, Younghee 1040 Hereford Drive Blue Bell Pennsylvania 19422 / US
	04 / CHAO, Wenchun 4665 Golden Ridge Trail Portage, MI 49024 / US
	[2012/10]
Representative(s)	Duckworth, Timothy John, et al J A Kemp 14 South Square Gray's Inn London WC1R 5JJ / GB
	[2013/40]
Former [2012/10]	McCluskie, Gail Wilson, et al J.A. Kemp & Co. 14 South Square Gray's Inn London WC1R 5JJ / GB
Application number, filing date	10770238.3	28.04.2010
	WO2010US32698
Priority number, date	US20090173869P	29.04.2009 Original published format: US 173869 P
	[2012/10]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2010126960
	Date:	04.11.2010
	Language:	EN
	[2010/44]
	Type:	A1 Application with search report
	No.:	EP2424368
	Date:	07.03.2012
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 04.11.2010 takes the place of the publication of the European patent application.
	[2012/10]
	Type:	B1 Patent specification
	No.:	EP2424368
	Date:	31.12.2014
	Language:	EN
	[2015/01]
Search report(s)	International search report - published on:	US	04.11.2010
	(Supplementary) European search report - dispatched on:	EP	14.09.2012
Classification	IPC:	A01N43/64, A61K31/53, C07D487/04, A61P35/00, A61P37/08, A61P37/06, A61P7/02	[2012/42]
	CPC:	A61K31/53 (EP,US); A61P29/00 (EP); A61P35/00 (EP); A61P35/02 (EP); A61P37/06 (EP); A61P37/08 (EP); (+) A61P43/00 (EP); A61P7/02 (EP); A61P9/10 (EP); C07D487/04 (EP,US) (-)
	C-Set:	A61K31/53, A61K2300/00 (EP,US)
	Former IPC [2012/10]	A01N43/64, A61K31/53
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2012/10]
Extension states	AL	Not yet paid
	BA	Not yet paid
	ME	Not yet paid
	RS	Not yet paid
Title	German:	PYRROLOTRIAZINVERBINDUNGEN	[2012/10]
	English:	PYRROLOTRIAZINE COMPOUNDS	[2012/10]
	French:	COMPOSÉS DE PYRROLOTRIAZINE	[2012/10]
Entry into regional phase	28.10.2011	National basic fee paid
	28.10.2011	Search fee paid
	28.10.2011	Designation fee(s) paid
	28.10.2011	Examination fee paid
Examination procedure	28.10.2011	Examination requested [2012/10]
	02.04.2013	Amendment by applicant (claims and/or description)
	24.05.2013	Despatch of a communication from the examining division (Time limit: M06)
	29.11.2013	Reply to a communication from the examining division
	14.08.2014	Communication of intention to grant the patent
	20.11.2014	Fee for grant paid
	20.11.2014	Fee for publishing/printing paid
	20.11.2014	Receipt of the translation of the claim(s)
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 24.05.2013
Opposition(s)	01.10.2015	No opposition filed within time limit [2015/50]
Fees paid	Renewal fee
	28.03.2012	Renewal fee patent year 03
	12.04.2013	Renewal fee patent year 04
	25.03.2014	Renewal fee patent year 05
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	HU	28.04.2010
	AT	31.12.2014
	BE	31.12.2014
	BG	31.12.2014
	CY	31.12.2014
	CZ	31.12.2014
	DK	31.12.2014
	EE	31.12.2014
	ES	31.12.2014
	FI	31.12.2014
	HR	31.12.2014
	IT	31.12.2014
	LT	31.12.2014
	LV	31.12.2014
	MC	31.12.2014
	MK	31.12.2014
	MT	31.12.2014
	NL	31.12.2014
	PL	31.12.2014
	RO	31.12.2014
	SE	31.12.2014
	SI	31.12.2014
	SK	31.12.2014
	SM	31.12.2014
	TR	31.12.2014
	NO	31.03.2015
	GR	01.04.2015
	IE	28.04.2015
	LU	28.04.2015
	CH	30.04.2015
	IS	30.04.2015
	LI	30.04.2015
	PT	01.05.2015
	[2018/30]
Former [2017/38]	HU	28.04.2010
	AT	31.12.2014
	BE	31.12.2014
	BG	31.12.2014
	CY	31.12.2014
	CZ	31.12.2014
	DK	31.12.2014
	EE	31.12.2014
	ES	31.12.2014
	FI	31.12.2014
	HR	31.12.2014
	IT	31.12.2014
	LT	31.12.2014
	LV	31.12.2014
	MC	31.12.2014
	MT	31.12.2014
	NL	31.12.2014
	PL	31.12.2014
	RO	31.12.2014
	SE	31.12.2014
	SI	31.12.2014
	SK	31.12.2014
	SM	31.12.2014
	TR	31.12.2014
	NO	31.03.2015
	GR	01.04.2015
	IE	28.04.2015
	LU	28.04.2015
	CH	30.04.2015
	IS	30.04.2015
	LI	30.04.2015
	PT	01.05.2015
Former [2017/03]	AT	31.12.2014
	BE	31.12.2014
	CZ	31.12.2014
	DK	31.12.2014
	EE	31.12.2014
	ES	31.12.2014
	FI	31.12.2014
	HR	31.12.2014
	IT	31.12.2014
	LT	31.12.2014
	LV	31.12.2014
	MC	31.12.2014
	MT	31.12.2014
	NL	31.12.2014
	PL	31.12.2014
	RO	31.12.2014
	SE	31.12.2014
	SI	31.12.2014
	SK	31.12.2014
	NO	31.03.2015
	GR	01.04.2015
	IE	28.04.2015
	LU	28.04.2015
	CH	30.04.2015
	IS	30.04.2015
	LI	30.04.2015
Former [2016/24]	AT	31.12.2014
	BE	31.12.2014
	CZ	31.12.2014
	DK	31.12.2014
	EE	31.12.2014
	ES	31.12.2014
	FI	31.12.2014
	HR	31.12.2014
	IT	31.12.2014
	LT	31.12.2014
	LV	31.12.2014
	MC	31.12.2014
	NL	31.12.2014
	PL	31.12.2014
	RO	31.12.2014
	SE	31.12.2014
	SI	31.12.2014
	SK	31.12.2014
	NO	31.03.2015
	GR	01.04.2015
	IE	28.04.2015
	LU	28.04.2015
	CH	30.04.2015
	IS	30.04.2015
	LI	30.04.2015
Former [2016/20]	AT	31.12.2014
	CZ	31.12.2014
	DK	31.12.2014
	EE	31.12.2014
	ES	31.12.2014
	FI	31.12.2014
	HR	31.12.2014
	IT	31.12.2014
	LT	31.12.2014
	LV	31.12.2014
	MC	31.12.2014
	NL	31.12.2014
	PL	31.12.2014
	RO	31.12.2014
	SE	31.12.2014
	SI	31.12.2014
	SK	31.12.2014
	NO	31.03.2015
	GR	01.04.2015
	IE	28.04.2015
	LU	28.04.2015
	CH	30.04.2015
	IS	30.04.2015
	LI	30.04.2015
Former [2016/12]	AT	31.12.2014
	CZ	31.12.2014
	DK	31.12.2014
	EE	31.12.2014
	ES	31.12.2014
	FI	31.12.2014
	HR	31.12.2014
	IT	31.12.2014
	LT	31.12.2014
	LV	31.12.2014
	MC	31.12.2014
	NL	31.12.2014
	PL	31.12.2014
	RO	31.12.2014
	SE	31.12.2014
	SI	31.12.2014
	SK	31.12.2014
	NO	31.03.2015
	GR	01.04.2015
	LU	28.04.2015
	CH	30.04.2015
	IS	30.04.2015
	LI	30.04.2015
Former [2016/06]	AT	31.12.2014
	CZ	31.12.2014
	DK	31.12.2014
	EE	31.12.2014
	ES	31.12.2014
	FI	31.12.2014
	HR	31.12.2014
	IT	31.12.2014
	LT	31.12.2014
	LV	31.12.2014
	MC	31.12.2014
	NL	31.12.2014
	PL	31.12.2014
	RO	31.12.2014
	SE	31.12.2014
	SK	31.12.2014
	NO	31.03.2015
	GR	01.04.2015
	LU	28.04.2015
	CH	30.04.2015
	IS	30.04.2015
	LI	30.04.2015
Former [2016/03]	AT	31.12.2014
	CZ	31.12.2014
	DK	31.12.2014
	EE	31.12.2014
	ES	31.12.2014
	FI	31.12.2014
	HR	31.12.2014
	IT	31.12.2014
	LT	31.12.2014
	LV	31.12.2014
	MC	31.12.2014
	NL	31.12.2014
	PL	31.12.2014
	RO	31.12.2014
	SE	31.12.2014
	SK	31.12.2014
	NO	31.03.2015
	GR	01.04.2015
	LU	28.04.2015
	IS	30.04.2015
Former [2016/01]	AT	31.12.2014
	CZ	31.12.2014
	DK	31.12.2014
	EE	31.12.2014
	ES	31.12.2014
	FI	31.12.2014
	HR	31.12.2014
	LT	31.12.2014
	LV	31.12.2014
	MC	31.12.2014
	NL	31.12.2014
	PL	31.12.2014
	RO	31.12.2014
	SE	31.12.2014
	SK	31.12.2014
	NO	31.03.2015
	GR	01.04.2015
	LU	28.04.2015
	IS	30.04.2015
Former [2015/52]	AT	31.12.2014
	CZ	31.12.2014
	DK	31.12.2014
	EE	31.12.2014
	ES	31.12.2014
	FI	31.12.2014
	HR	31.12.2014
	LT	31.12.2014
	LV	31.12.2014
	NL	31.12.2014
	PL	31.12.2014
	RO	31.12.2014
	SE	31.12.2014
	SK	31.12.2014
	NO	31.03.2015
	GR	01.04.2015
	LU	28.04.2015
	IS	30.04.2015
Former [2015/49]	AT	31.12.2014
	CZ	31.12.2014
	DK	31.12.2014
	EE	31.12.2014
	ES	31.12.2014
	FI	31.12.2014
	HR	31.12.2014
	LT	31.12.2014
	LV	31.12.2014
	NL	31.12.2014
	PL	31.12.2014
	RO	31.12.2014
	SE	31.12.2014
	SK	31.12.2014
	NO	31.03.2015
	GR	01.04.2015
	IS	30.04.2015
Former [2015/38]	AT	31.12.2014
	CZ	31.12.2014
	ES	31.12.2014
	FI	31.12.2014
	HR	31.12.2014
	LT	31.12.2014
	LV	31.12.2014
	NL	31.12.2014
	PL	31.12.2014
	RO	31.12.2014
	SE	31.12.2014
	SK	31.12.2014
	NO	31.03.2015
	GR	01.04.2015
	IS	30.04.2015
Former [2015/37]	CZ	31.12.2014
	ES	31.12.2014
	FI	31.12.2014
	HR	31.12.2014
	LT	31.12.2014
	LV	31.12.2014
	NL	31.12.2014
	PL	31.12.2014
	RO	31.12.2014
	SE	31.12.2014
	SK	31.12.2014
	NO	31.03.2015
	GR	01.04.2015
Former [2015/36]	CZ	31.12.2014
	ES	31.12.2014
	FI	31.12.2014
	HR	31.12.2014
	LT	31.12.2014
	LV	31.12.2014
	NL	31.12.2014
	RO	31.12.2014
	SE	31.12.2014
	NO	31.03.2015
	GR	01.04.2015
Former [2015/33]	ES	31.12.2014
	FI	31.12.2014
	HR	31.12.2014
	LT	31.12.2014
	LV	31.12.2014
	NL	31.12.2014
	SE	31.12.2014
	NO	31.03.2015
	GR	01.04.2015
Former [2015/29]	FI	31.12.2014
	HR	31.12.2014
	LT	31.12.2014
	LV	31.12.2014
	NL	31.12.2014
	SE	31.12.2014
	NO	31.03.2015
	GR	01.04.2015
Former [2015/24]	FI	31.12.2014
	HR	31.12.2014
	LT	31.12.2014
	LV	31.12.2014
	SE	31.12.2014
	NO	31.03.2015
	GR	01.04.2015
Former [2015/23]	FI	31.12.2014
	LT	31.12.2014
	NO	31.03.2015
Former [2015/21]	LT	31.12.2014
	NO	31.03.2015
Former [2015/20]	LT	31.12.2014
Documents cited:	Search	[ID]WO2007056170 (BAYER PHARMACEUTICALS CORP [US], et al) [ID] 1-12,14-16 * the whole document * * page 1, paragraph 1; claims 1-7 *;
		[A]WO2005014599 (CELLULAR GENOMICS INC [US], et al) [A] 1-16 * the whole document *;
		[A]WO2006099075 (CGI PHARMACEUTICALS INC [US], et al) [A] 1-16 * the whole document *;
		[A]WO2005047290 (CELLULAR GENOMICS INC [US], et al) [A] 1-16 * the whole document *;
		[A]WO2005037836 (OSI PHARM INC [US], et al) [A] 1-16 * the whole document *;
		[A]WO0017203 (BASF AG [DE], et al) [A] 1-16 * the whole document *;
		[A]WO03016338 (PARKER HUGHES INST [US], et al) [A] 1-16 * the whole document *
	International search	[Y]WO2005037836 (OSI PHARM INC [US], et al);
		[Y]WO0017203 (BASF AG [DE], et al);
		[Y]WO03016338 (PARKER HUGHES INST [US], et al)
	by applicant	- NATURE, (1993), vol. 361, pages 226 - 233

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 35p